Nirav Modi's judicial custody extended till Sept 19 by London court

Agencies

August 22, 2019

London, Aug 22: A London Westminster Magistrates' Court on Thursday extended the judicial custody of fugitive diamantaire Nirav Modi till September 19 in connection with Rs 13,500- crore Punjab National Bank (PNB) fraud and money laundering case.

The 48-year-old businessman appeared before the court via video link from Wandsworth prison in south-west London, where he is currently lodged.

Judge Tan Ikram directed the court authorities to seek confirmation of the five-day extradition hearing starting May 11, 2020.
A case management hearing may also take place in February next year.

The diamantaire and his nephew Mehul Choksi are the main accused in the PNB loan default case. The duo fled the country in January last year before the scam came to light.

Modi was arrested on March 19 by Scotland Yard in connection with the case and is in prison since then.

He has not returned to India despite repeated summonses from Indian probe agencies and courts. India is seeking his extradition to make him face the law of the land for allegedly committing the economic offences.

Comments

Add new comment

Coastaldigest.com reserves the right to delete or block any comments.
Coastaldigset.com is not responsible for its readers’ comments.
Comments that are abusive, incendiary or irrelevant are strictly prohibited.
Please use a genuine email ID and provide your name to avoid reject.

AstraZeneca to withdraw Covid-19 vaccine globally as demand dips after admitting side effects

News Network

May 8,2024

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments